BCLI · Categories · Form 4

BCLI - SEC Form 4 insider transactions

Brainstorm Cell Therapeutics Inc. (BCLI) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for BCLI

• 10d
  President & CEO Lebovits Chaim was granted 1,800,000 shares, increasing direct ownership by 896% to 2,000,960 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 10d
  EVP & Chief Business Officer Yablonka Uri was granted 150,000 shares, increasing direct ownership by 219% to 218,464 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 10d
  Officer Patlis Alla was granted 100,000 shares, increasing direct ownership by 225% to 144,349 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 10d
  Director Frenkel Jacob A was granted 200,000 shares, increasing direct ownership by 457% to 243,777 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 10d
  Director Arbel Irit was granted 120,000 shares, increasing direct ownership by 292% to 161,054 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 19d
  SEC Form 4 filed by Director Bairu Menghisteab

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 19d
  SEC Form 4 filed by Director Polverino Anthony J.

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 19d
  SEC Form 4 filed by Director Hartounian Hartoun

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 19d
  SEC Form 4 filed by Director Lindborg Stacy

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 19d
  SEC Form 4 filed by Director Naor Nir

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 19d
  SEC Form 4 filed by Director Dagher Ibrahim B.

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 517d
  Chief Medical Officer Dagher Ibrahim B. was granted 50,000 shares, increasing direct ownership by 297% to 66,849 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 521d
  President & CEO Lebovits Chaim was granted 120,000 shares, increasing direct ownership by 148% to 200,960 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 521d
  Director Frenkel Jacob A was granted 40,000 shares, increasing direct ownership by 1,059% to 43,777 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 521d
  Director Polverino Anthony J. was granted 24,000 shares, increasing direct ownership by 1,387% to 25,730 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 521d
  EVP & Chief Business Officer Yablonka Uri was granted 60,000 shares, increasing direct ownership by 709% to 68,464 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 521d
  Officer Patlis Alla was granted 40,000 shares, increasing direct ownership by 920% to 44,349 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 521d
  Director Naor Nir was granted 30,666 shares, increasing direct ownership by 3,838% to 31,465 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 521d
  Director Lindborg Stacy was granted 20,000 shares, increasing direct ownership by 71% to 48,229 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 521d
  EVP, Chief Operating Officer Hartounian Hartoun was granted 50,000 shares, increasing direct ownership by 2,500% to 52,000 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 521d
  Director Bairu Menghisteab was granted 24,000 shares (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 521d
  Director Arbel Irit was granted 30,666 shares, increasing direct ownership by 295% to 41,054 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 685d
  Chief Medical Officer Dagher Ibrahim B. sold $22,069 worth of shares (63,000 units at $0.35), closing all direct ownership in the company (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 713d
  EVP, Chief Operating Officer Hartounian Hartoun was granted 30,000 shares (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 736d
  Lebovits Chaim was granted 15,000 shares, increasing direct ownership by 1% to 1,164,865 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 747d
  Lebovits Chaim was granted 50,000 shares, increasing direct ownership by 5% to 1,149,865 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 756d
  Lebovits Chaim was granted 40,000 shares, increasing direct ownership by 4% to 1,099,865 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 762d
  Lebovits Chaim was granted 66,300 shares, increasing direct ownership by 7% to 1,059,865 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 763d
  Lebovits Chaim was granted 135,000 shares, increasing direct ownership by 16% to 993,565 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 775d
  Lebovits Chaim was granted 15,000 shares, increasing direct ownership by 2% to 858,565 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 781d
  Lebovits Chaim was granted 245,072 shares, increasing direct ownership by 41% to 843,565 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 817d
  Lindborg Stacy was granted 241,935 shares, increasing direct ownership by 133% to 423,435 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 817d
  Yablonka Uri was granted 109,426 shares, increasing direct ownership by 624% to 126,969 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 817d
  Patlis Alla was granted 65,246 shares (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 817d
  Lebovits Chaim was granted 305,198 shares, increasing direct ownership by 104% to 598,493 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1007d
  SEC Form 4: Lindborg Stacy bought $20,402 worth of shares (11,500 units at $1.77), increasing direct ownership by 7% to 181,500 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1037d
  SEC Form 4: Lindborg Stacy was granted 35,000 shares, increasing direct ownership by 26% to 170,000 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1040d
  SEC Form 4: Lebovits Chaim was granted 31,185 shares, increasing direct ownership by 12% to 293,295 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1084d
  SEC Form 4 filed by Naor Nir

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1135d
  SEC Form 4 filed by Taylor Kirk

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1142d
  SEC Form 4 filed by Lebovits Chaim

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1142d
  SEC Form 4 filed by Lindborg Stacy

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1252d
  SEC Form 4: Lindborg Stacy was granted 35,000 shares, increasing direct ownership by 140% to 60,000 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1252d
  SEC Form 4: Lebovits Chaim was granted 31,185 shares, increasing direct ownership by 20% to 187,110 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1523d
  SEC Form 4 filed by Frenkel Jacob A

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1547d
  SEC Form 4: Kern Ralph Dr. was granted 35,885 shares, increasing direct ownership by 19% to 223,310 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1586d
  SEC Form 4: Polverino Anthony J. was granted 3,882 shares, increasing direct ownership by 18% to 25,960 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1634d
  SEC Form 4: Almenoff June Sherie was granted 2,000 shares, increasing direct ownership by 50% to 6,000 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1634d
  SEC Form 4: Polverino Anthony J. was granted 2,000 shares, increasing direct ownership by 10% to 22,078 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1634d
  SEC Form 4: Taub Malcolm S was granted 12,000 shares, increasing direct ownership by 18% to 77,332 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1634d
  SEC Form 4 filed by Yablonka Uri

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1634d
  SEC Form 4 filed by Arbel Irit

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1641d
  SEC Form 4: Kern Ralph Dr. was granted 35,885 shares, increasing direct ownership by 24% to 187,425 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1641d
  SEC Form 4: Lebovits Chaim was granted 31,185 shares, increasing direct ownership by 25% to 155,925 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1641d
  SEC Form 4: Taub Malcolm S was granted 12,000 shares, increasing direct ownership by 23% to 65,332 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1641d
  SEC Form 4: Polverino Anthony J. was granted 4,216 shares, increasing direct ownership by 27% to 20,078 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1641d
  SEC Form 4 filed by Arbel Irit

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1641d
  SEC Form 4 filed by Frenkel Jacob A

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1641d
  SEC Form 4: Abbhi Sankesh was granted 6,666 shares, increasing direct ownership by 143% to 11,323 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1641d
  SEC Form 4 filed by Yablonka Uri

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)

Other BCLI categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends